Elite Pharmaceuticals Inc (ELTP)

[toofun]

quote:

Gerhard noted that abuse-deterrent labeling could give patients and physicians the wrong impression: "If prescribers think it's safer and that patients are less likely to get addicted,...

Really? If I give a patient an opiate that is abuse deterrent he's safe from addiction. Its this kind of specious reasoning thats creates a air of professional incompetence that is helping bring down what input the highest level of direct care givers have - the physician.

Not that the FDA shouldn't need a broad swath of opinion but some of these contributors are making things more difficult to treat in the real world, outside of the ivory tower.